Additionally, a positive association between IGF-1R and better clinical outcomes in hormone receptor positive, HER2 negative tumors was recently reported [75], while in another luminal subtype group, IGF-1R mRNA has been significantly correlated with improved BrCa-specific survival (BCSS). Here, IGF1R is linked to invasive breast carcinoma.